Ballicules.com

Lanthanum carbonate

FOSRENOL

Lanthanum carbonate ballicule: receptor binding, kinetics and half-life diagram
Mechanism of action: Lanthanum carbonate ballicule

What it isNon-absorbed phosphate binder; hyperphosphatemia in dialysis.

Why this oneChewable, calcium-free and effective at a lower tablet burden than sevelamer.

What limits itTablets must be chewed thoroughly or they do not work. GI upset; long-term tissue deposition is of uncertain significance.

Lanthanum carbonate molecular structure (skeletal formula)
Molecular structure: Lanthanum carbonate

Principal riskTablets must be chewed thoroughly or they do not work

Classes and tags

Clinical profile

Therapeutic safety burden1 / 4
Overdose danger0 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk0 / 4

Legacy pregnancy categoryUnknown / historical label unavailable

Defining liabilityLocal irritation, sensitization or administration-site injury; negligible systemic toxicity at usual use.

FDA label

NO BOXED WARNINGS

FDA dosingPopulationStartTargetMax
Hyperphosphatemia (ESRD)Adults1,500 mg/day in divided doses with meals1,500-3,000 mg/day4,500 mg/day

Titration Titrate every 2 to 3 weeks based on serum phosphate

Renal Undefined

Hepatic Undefined

Binds other orally administered drugs — separate their administration

Instructions

Available strengths

Contraindications

Cautions

Adverse reactions

Pregnancy Insufficient data; use a non-lanthanum phosphate binder in pregnancy

Lactation No data; use a non-lanthanum phosphate binder while lactating

Cost

Lanthanum carbonate (FOSRENOL)
What pharmacies pay · NADAC 9/30/26
Strength#/mogeneric $/unitCostPlus
500 mgchew tabper unit$3.18/eaoffered
750 mgchew tabper unitoffered
1000 mgchew tabper unit$3.15/eaoffered
750 mgpowderper unitnot offered
1000 mgpowderper unitnot offered

Generic entry2017

Open Lanthanum carbonate in the interactive console ↗

Self-check